Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Palantir Technologies shares hit a record high as the company benefited from demand for its artificial intelligence software. U.S. equities were higher at midday, boosted by tech shares. The Nasdaq ...

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

Merck swung to a quarterly profit as sales grew to beat Wall Street’s estimates, although the drug company’s outlook for 2025 ...

The markets are likely to show some reactions to Donald Trump’s trade war, sparked by the US imposing sweeping tariffs on ...

Senator, Dr. Rasha Kelej, CEO of Merck Foundation and President of "More Than a Mother" Campaign has been recognized as One ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...

Whether you’re recruiting for these roles in particular or simply curious about broader labor market trends, read on for the full rankings and reflections on the most in-demand jobs. This story ...